Health Updates: From Biosimilars to Bird Flu

Recent health news includes Amgen's launch of an Eylea biosimilar in the U.S., Slovakia's bird flu outbreak, and China's obesity guidelines. Starboard addresses Kenvue's performance, McDonald's faces E. coli repercussions, and Walmart advances in drug delivery. Germany and Norway detect new mpox cases, and Eurofins rebuts financial allegations.

In recent health developments, biotech company Amgen has been approved to launch its biosimilar version of Eylea, overcoming Regeneron's appeal. This decision paves the way for Amgen's new treatment for eye diseases.

A concerning avian influenza outbreak has been reported in Slovakia, as confirmed by the World Organisation for Animal Health. The H5N1 virus devastated a poultry farm, reflecting a broader European uptick in cases this season.

In efforts to combat its obesity epidemic, China's National Health Commission has released its first standardized obesity management guidelines, marking a crucial step amid growing health challenges.

(With inputs from agencies.)